ReviewBriefings in bioinformatics2026
Machine learning for RNA-small molecule interactions: methodologies, evaluation, and future directions.
Review in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
RNA is emerging as a compelling therapeutic target due to its rich structural diversity and central involvement in gene regulation, splicing, translation, and cellular signaling. Alongside advances in structural biology, computational approaches, especially machine learning and deep learning, have transformed the systematic analysis of RNA-small molecule interactions. In this paper, we provide a comprehensive survey of computational methods for RNA-small molecule interaction prediction, with a particular emphasis on three core tasks: binding site prediction, binding preference prediction, and binding pose prediction. We first summarize the data resources commonly used to support these tasks and outline molecular representations that capture RNA structural features and the chemical properties of small molecules. We then review a spectrum of computational approaches for the above three tasks, ranging from statistical methods and traditional machine learning to deep learning. We further evaluate representative methods for each task, providing insights into their respective strengths and limitations. Finally, we highlight open challenges in current research on RNA-small molecule interactions, including limited data availability, the black-box nature of the models, and the growing need for generative modeling. We discuss emerging directions such as data augmentation, model interpretability, and RNA-targeted small-molecule design as promising pathways to address these challenges and advance rational RNA-targeted drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.